908 Devices (NASDAQ:MASS) and Know Labs (OTCMKTS:KNWN) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.
Insider & Institutional Ownership
31.3% of 908 Devices shares are owned by institutional investors. 51.1% of 908 Devices shares are owned by company insiders. Comparatively, 27.3% of Know Labs shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
This table compares 908 Devices and Know Labs’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|908 Devices||$26.89 million||43.20||-$12.82 million||($1.24)||-34.31|
|Know Labs||$120,000.00||618.47||-$13.56 million||N/A||N/A|
908 Devices has higher revenue and earnings than Know Labs.
This is a breakdown of current ratings and price targets for 908 Devices and Know Labs, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
908 Devices currently has a consensus target price of $68.00, suggesting a potential upside of 59.81%. Given 908 Devices’ higher possible upside, analysts clearly believe 908 Devices is more favorable than Know Labs.
This table compares 908 Devices and Know Labs’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
908 Devices beats Know Labs on 8 of the 10 factors compared between the two stocks.
About 908 Devices
908 Devices Inc. develops and sells measurement devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and the Asia Pacific. It offers handheld and desktop mass spectrometry (Mass Spec) devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
About Know Labs
Know Labs, Inc., develops, markets, and sells proprietary technologies in the United States. Its proprietary platform technologies include ChromaID and Bio-RFID technologies that utilize electromagnetic energy along the electromagnetic spectrum to perform analytics, which allow the user to identify, authenticate, and diagnose various organic and non-organic materials and substances. The company, through its subsidiary TransTech Systems, Inc., distributes products for employee and personnel identification and authentication. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.
Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.